UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease
Clinical trial NCT05812612 · UNKNOWN
Trial details
- NCT number
- NCT05812612
- Sponsor
- Beijing Ditan Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-30
- Primary completion
- 2023-12-30
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.